Risk Reduction Strategy and Analysis of Advantages and Drawbacks for Octabromodiphenyl Ether Final Report Prepared for Department for Environment, Food and Rural Affairs Contract Reference: 16/13/33 RPA June 2002 OCTABROMODIPHENYL ETHER RISK REDUCTION STRATEGY AND ANALYSIS OF ADVANTAGES AND DRAWBACKS FINAL REPORT June 2002 prepared for Department for Environment, Food and Rural Affairs by Risk & Policy Analysts Limited, Farthing Green House, 1 Beccles Road, Loddon, Norfolk, NR14 6LT, UK Tel: +44 1508 528465 Fax: +44 1508 520758 Email:
[email protected] Web: www.rpaltd.co.uk RPA REPORT - ASSURED QUALITY Project: Ref/Title J355I/Octa Approach: In accordance with tender specification, RPA proposal and Steering Group input Report Status: Final Report Prepared by: Caspar Corden, Consultant Meg Postle, Director Approved for issue by: Meg Postle, Director Date: 24 June 2002 If printed by RPA, this report will be printed on 100% recycled, chlorine-free paper Risk & Policy Analysts EXECUTIVE SUMMARY 1. Introduction Under Regulation 793/93/EEC, octabromodiphenyl ether is a priority substance for risk assessment and, where necessary, risk management, at the European Union level. The UK and France are jointly responsible for addressing the risks associated with octabromodiphenyl ether (for the environment and human health respectively). Both the human health and environmental risk assessments have identified areas where there is a need for risk reduction. Furthermore, both have identified areas where there is a need for further information and/or testing and, given the uncertainties, where there may be a need for precautionary action to be taken to reduce the risks. The Department for Environment, Food and Rural Affairs (DEFRA) has contracted Risk & Policy Analysts Limited (RPA) to develop the risk reduction strategy for octabromodiphenyl ether.